Placebo | CLM | p valuea | p valueb | ||
---|---|---|---|---|---|
Mean ± SD | |||||
Blood glucose | Baseline | 147.4 ± 48.4 | 148.3 ± 56.6 | 0.945 | |
after 12 weeks | 138.4 ± 59.0 | 143.4 ± 56.8 | 0.737 | ||
Differencec | -9.0 ± 67.1 | -4.9 ± 0.2 | 0.775 | ||
p valued | 0.444 | 0.484 | 0.751 | ||
HbA1c | Baseline | 5.7 ± 0.6 | 5.8 ± 0.5 | 0.638 | |
after 12 weeks | 5.8 ± 0.5 | 5.8 ± 0.6 | 0.976 | ||
Differencec | 0.1 ± 0.1 | 0.0 ± 0.1 | 0.417 | ||
p valued | 0.711 | 0.358 | 0.502 | ||
Insulin | Baseline | 6.8 ± 4.8 | 7.0 ± 5.5 | 0.870 | |
after 12 weeks | 7.3 ± 8.0 | 5.3 ± 5.3 | 0.269 | ||
Differencec | 0.5 ± 3.2 | -1.7 ± 0.2 | 0.243 | ||
p valued | 0.686 | 0.226 | 0.172 | ||
C-peptide | Baseline | 2.2 ± 1.0 | 2.2 ± 1.0 | 0.839 | |
after 12 weeks | 2.2 ± 1.4 | 1.8 ± 0.7 | 0.104 | ||
Differencec | 0.0 ± 0.4 | -0.4 ± 0.3 | 0.074 | 0.025* | |
p valued | 0.898 | 0.010* |